SCHEMBL8086798

SCHEMBL8086798

CCCCOc1nc(-c2cccc(C)c2)c(-c2ccc(S(N)(=O)=O)cc2)cc1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 3/20 0.44
PTGS1 P23219 2/20 0.44
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CNR1 P21554 7/20 0.43
TTK P33981 2/20 0.42
MAPK8 P45983 2/20 0.42
CA12 O43570 1/20 0.40
TSHR P16473 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
LRRK2 Q5S007 1/20 0.37
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
KDM1A O60341 1/20 0.36
CA5A P35218 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
POLB P06746 1/20 0.36
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086716 0.92 PTGS2 (0.53) PTGS2PTGS1CNR1
SCHEMBL8087099 0.91 PTGS2 (0.48) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8094646 0.89 PTGS2 (0.42) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8093993 0.89 CNR1 (0.47) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8094547 0.86 PTGS2 (0.60) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8098696 0.85 PTGS2 (0.47) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8094676 0.85 PTGS2 (0.61) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8098703 0.84 PTGS2 (0.41) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8095632 0.83 PTGS2 (0.56) PTGS2PTGS1CA1CA2CNR1
SCHEMBL8092693 0.83 PTGS2 (0.50) PTGS2PTGS1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP claimed
EP-0808304-B1 2,3-SUBSTITUTED PYRIDINES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2000-12-27 EP disclosed